Pressmeddelanden

Glactone Pharma receives funding from Swelife and Medtech4health

2018-05-24 10:45 CEST
​Glactone Pharma, in collaboration with researchers from Karolinska Institutet and Lund...

Den Blå Handsken –stödjer prostatacancerforskningen i samarbete med Prostatacancerförbundet

Den Blå Handsken –stödjer prostatacancerforskningen i samarbete med Prostatacancerförbundet

2017-04-13 05:20 CEST
Varje dag får 27 män i Sverige diagnosen prostatacancer. Som tillverkare av arbetshands...

​Urbanista x Movember Foundation

​Urbanista x Movember Foundation

2016-10-12 13:17 CEST
Urbanista initiates cooperation with the Movember Foundation and creates headphones to ...

Glactone Pharma announces appointments to new Scientific Advisory Board

2016-02-04 06:00 CET
​Glactone Pharma is pleased to announce the appointment of leading experts to its newly...

Glactone Pharma is awarded financing from VINNOVA

2015-12-14 09:05 CET
​Glactone Pharma has been awarded financing from the VINNOVA. Glactone Pharma is active...

Glactone Pharma is granted a European patent

2015-09-09 07:00 CEST
The patent relates to novel synthetic analogs of the STAT3 inhibitor GPA500 with improv...

Glactone Pharma innovators publish new study showing that the STAT3 inhibitor galiellalactone reduces tumor growth and metastatic spread in an animal model of prostate cancer

2015-07-07 12:00 CEST
Members of Glactone Pharma’s innovator group have published an article in the highly ra...

American Society of Clinical Oncology (ASCO): Glactone Pharma demonstrates that new compound reduces immunosuppressive markers in prostate cancer cells

2015-05-22 06:10 CEST
Glactone Pharma has generated new exciting data demonstrating that the STAT3 inhibitor ...